Daewon Atropine Sulfate Injection

Adult administration

○ Adults 1. Inject 0.5 mg of atropine sulfate hydrate subcutaneously or intramuscularly per dose. Intravenous injection may be used depending on the circumstances. 2. Organophosphate insecticide poisoning 1) Mild: Inject 0.5-1 mg of atropine sulfate hydrate subcutaneously. 2) Moderate: Inject 1-2 mg of this medicine subcutaneously or intramuscularly and repeat at 20-30-minute intervals if needed. 3) Severe: Inject 2-4 mg of this medicine intravenously and repeat according to symptoms until signs of atropine saturation appear. Adjust the dose as appropriate according to age and symptoms.

This medication is an injectable ampoule, and care should be taken when cutting the container as glass fragments may be mixed in. Special caution should be taken when being administered to children or the elderly. This medication should not be used in patients with glaucoma, urinary disorders due to prostatic hypertrophy, patients with paralytic ileus, those allergic to this medication, and patients with asthma. It should be administered cautiously to patients with prostatic hypertrophy, severe cardiac disease, ulcerative colitis, hyperthyroidism, individuals in high-temperature environments, and patients over 40 years old. When using this medication, pupils may dilate, and symptoms such as inability to accommodate, glaucoma, and blurred vision may appear. Additionally, neurological symptoms such as headaches and dizziness, as well as gastrointestinal symptoms like dry mouth, nausea, and constipation may occur. There may also be rapid heartbeat or difficulty in breathing, and if skin rashes or allergic symptoms appear, use should be discontinued immediately. If severe allergic reactions occur, appropriate treatment is necessary. Urinary disturbances may occur, and facial flushing may also be experienced. During the use of this medication, visual disturbances might occur, so it is advisable to avoid driving vehicles or operating dangerous machinery. When using with other medications, be cautious of interactions. Using with anticholinergic drugs or certain antidepressants, antihistamines, cardiac glycosides, etc., may enhance effects or worsen side effects. It is advisable for women who are pregnant or of childbearing potential, as well as nursing mothers, to avoid using this medication as it may affect the fetus or newborn, potentially causing increased heart rate, and could reduce milk secretion. Safety in children has not been established, and there is a lack of experience with its use. Elderly individuals should use this medication with more caution since side effects such as glaucoma, memory impairment, dry mouth, urinary difficulties, and constipation may more easily occur.

• pupil dilation
• accommodation disorder
• glaucoma
• blurred vision
• headache
• heaviness
• visual disturbances
• dizziness
• dry mouth
• nausea

This medication may be sensitive to light, therefore, it should be stored in a light-protective container that does not allow light to enter. It is also important to store it in a sealed container to avoid contact with air.

Appearance

A colorless and transparent liquid is filled in a brown ampoule, which has an unpleasant irritating bitter taste. For export: A colorless and transparent liquid is filled in an ampoule, which has an unpleasant irritating bitter taste.

Package unit

Domestic use: 1mL/ampoule x 50, export: 1mL/ampoule x 10, 50